Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study

BACKGROUND: Calprotectin is a biomarker of disease activity in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and predicts relapse in juvenile idiopathic arthritis. Higher drug trough serum levels are associated with a good response in patients treated with tumor necrosis factor inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Inciarte-Mundo, José, Ramirez, Julio, Hernández, Maria Victoria, Ruiz-Esquide, Virginia, Cuervo, Andrea, Cabrera-Villalba, Sonia Raquel, Pascal, Mariona, Yagüe, Jordi, Cañete, Juan D., Sanmarti, Raimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292085/
https://www.ncbi.nlm.nih.gov/pubmed/30545393
http://dx.doi.org/10.1186/s13075-018-1764-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292085/
https://www.ncbi.nlm.nih.gov/pubmed/30545393
http://dx.doi.org/10.1186/s13075-018-1764-z

Ejemplares similares